Weight loss is no longer a guessing game.
With the STAAR GPS Protocol™, patients and providers now have a smarter, science-backed way to navigate metabolic health in a post-compounded semaglutide and tirzepatide world.
What Is the STAAR GPS Protocol™?
The STAAR GPS Protocol™ stands for:
GLP-1 Receptor Agonist
Pramlintide
SLM+ by STAAR LABS
This strategic 3-part protocol combines pharmaceutical precision with nutraceutical innovation to deliver powerful, sustainable weight loss results. GPS™ helps optimize the effects of GLP-1 therapy, address common metabolic challenges, and support long-term patient success.
Why GPS Was Created: Solving Today’s Weight Loss Crisis
GLP-1 medications like semaglutide and tirzepatide revolutionized weight loss—but legal and supply constraints have left patients stranded. The FDA has removed compounded semaglutide and tirzepatide from the shortage list. Branded options now cost $1,000+ per month, pricing many patients out of care.
Enter STAAR GPS™.
We developed the GPS Protocol™ to deliver:
-
Clinical-grade alternatives to banned or restricted compounds
-
Enhanced synergy between GLP-1, amylin (via pramlintide), and SLM+
-
Real-world affordability and access for patients and providers
The goal? A safe, legal, and proven path to metabolic transformation.
The Science Behind the Stack
Together, these three components tackle:
✅ Appetite regulation
✅ Insulin resistance
✅ Muscle preservation
✅ Plateau prevention
What Makes GPS™ Different
Most weight loss protocols focus on just one pathway.
STAAR GPS™ engages three:
-
GLP-1 Pathway — to suppress hunger and improve blood sugar
-
Amylin Pathway — to increase fullness and stabilize energy
-
GIP-Like Effects — to protect metabolism and preserve lean tissue
SLM+, our proprietary supplement, is the metabolic “fuel” that supports this triad, working with your biology instead of against it.
Where to Start
There are currently two versions of the protocol based on your needs:
-
GPS-L™: Liraglutide + Pramlintide + SLM+
-
GPS-D™: Dulaglutide + Pramlintide + SLM+
Your provider will help you choose the right formulation.
All STAAR GPS™ protocols are available through licensed providers and pharmacies in our clinical network.
Clinics and Providers: Apply to Offer STAAR GPS™
What People Are Saying
“My patients are finally seeing the weight loss they were promised—without the price tag or legal gray areas.”
– Dr. A. Simmons, Weight Loss Clinic Director
“The GPS Protocol gave me back control. I was stuck, tired, and gaining. Now I’m down 18 lbs in 10 weeks.”
– Megan L., Patient, Age 47
Legal. Compliant. Transparent.
Every STAAR GPS™ protocol is:
-
Prescribed by licensed medical providers
-
Fulfilled through FDA-registered or State Licensed compounding pharmacies
-
Supported by research-informed supplement strategies
We do not use or promote banned or restricted GLP-1 compounds.
All ingredients in SLM+ are compliant with FDA DSHEA guidelines and manufactured in GMP-certified U.S. facilities.
Disclaimers
Medical Disclaimer: This content is provided for informational and educational purposes only and is not intended as medical advice. The STAAR GPS Protocol™ involves prescription medications that must be prescribed and managed by a licensed healthcare provider. Individual results may vary, and treatment decisions should be made based on clinical judgment and patient-specific factors.
Supplement Disclaimer: SLM+ by STAAR LABS is a dietary supplement. These statements have not been evaluated by the Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease. SLM+ should not be considered a replacement for medical treatment or medication unless directed by a healthcare provider.
Compliance Note: STAAR LABS does not sell prescription medications. All pharmaceuticals referenced in the GPS Protocol™ are available only through licensed providers and compounding pharmacies operating in compliance with state and federal law.
Research & Innovation Disclosure: STAAR LABS collaborates with clinics, pharmacies, and healthcare professionals to advance innovation in real-world metabolic health protocols. Our research focuses on the integration of nutraceutical and pharmaceutical strategies to support improved outcomes. This content may reference investigational or emerging clinical practices that require further validation.
